Trials / Conditions / Ganglioneuroblastoma, Nodular
Ganglioneuroblastoma, Nodular
4 registered clinical trials studyying Ganglioneuroblastoma, Nodular — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma NCT06858501 | Children's Oncology Group | Phase 2 |
| Recruiting | Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly NCT06172296 | National Cancer Institute (NCI) | Phase 3 |
| Active Not Recruiting | Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozol NCT04385277 | Children's Oncology Group | Phase 2 |
| Recruiting | Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (N NCT03126916 | Children's Oncology Group | Phase 3 |